From wiki-pain
Revision as of 15:18, 23 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.23
First Reported 2009
Last Reported 2010
Negated 1
Speculated 1
Reported most in Body
Documents 3
Total Number 4
Disease Relevance 3.05
Pain Relevance 0.35

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (SRA1) cell proliferation (SRA1) nucleus (SRA1)
DNA binding (SRA1) cytoplasm (SRA1)
Anatomy Link Frequency
muscles 1
lung 1
extremity 1
SRA1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Pain 16 98.04 Very High Very High Very High
fibrosis 69 92.96 High High
imagery 2 18.88 Low Low
Arthritis 1 6.64 Low Low
Inflammation 7 5.00 Very Low Very Low Very Low
addiction 3 5.00 Very Low Very Low Very Low
metalloproteinase 3 5.00 Very Low Very Low Very Low
antagonist 3 5.00 Very Low Very Low Very Low
corticosteroid 2 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Emphysema 2 98.64 Very High Very High Very High
Pain 14 98.04 Very High Very High Very High
Disease 24 97.76 Very High Very High Very High
Cancer 27 96.92 Very High Very High Very High
Pulmonary Disease 64 96.32 Very High Very High Very High
Nicotine Addiction 9 95.52 Very High Very High Very High
Idiopathic Pulmonary Fibrosis 69 92.96 High High
Metastasis 13 89.44 High High
Recurrence 11 88.56 High High
Femoral Neck Fractures 10 84.76 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Radiographs at that time showed no significant change in hip SRA placement, but mild lower extremity shortening due to initial positional change of the femoral component.
Neg (no) Regulation (change) of hip SRA in extremity
1) Confidence 0.23 Published 2010 Journal Patient Saf Surg Section Body Doc Link PMC2829516 Disease Relevance 0.37 Pain Relevance 0.23
New therapies targeting the Receptor Activator of NF-?
Regulation (targeting) of Receptor Activator
2) Confidence 0.02 Published 2010 Journal Diagn Pathol Section Body Doc Link PMC2954972 Disease Relevance 1.43 Pain Relevance 0
However, considering the significant sensitivity of interstitial sVEGFR1 to transport rates, we cannot rule out the possibility that once sVEGFR1-heterodimerization with surface VEGFRs is in place, that transport rates may indeed affect the formation of signaling complexes in muscles.
Spec (may) Regulation (affect) of complexes in muscles
3) Confidence 0.00 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2663039 Disease Relevance 0 Pain Relevance 0
These findings suggest that the changes in the Hb monomers and/or complexes may be related to a specific type of parenchymal lung damage.
Regulation (changes) of complexes in lung
4) Confidence 0.00 Published 2010 Journal Respir Res Section Body Doc Link PMC2949726 Disease Relevance 1.25 Pain Relevance 0.12

General Comments

This test has worked.

Personal tools